Search

Author/Creator Cao, Hengsong

1. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Issue 2 (14th February 2023)

Authors:
Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy. Issue 12 (20th December 2022)

Authors:
Sun, Guangshun; Liu, Hanyuan; Zhao, Jie; Zhang, Jinyu; Huang, Tian; Sun, Guoqiang; Zhao, Siqi; Zhang, Zihao; Cao, Hengsong; Rong, Dawei; Kong, Xiangyi; Ji, Qinghua; Liu, Li; Wang, Xuehao; Tang, Weiwei; Xia, Yongxiang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 12(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search